IP Library Granted Patent US 7,449,452
Granted Patent B2
US 7,449,452 · App. 11/580,936 · Granted Nov 11, 2008

Method for estimating immunostimulant activity of a polysaccharide

Assignee: Ajinomoto Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,449,452
App. No.
11/580,936
Granted
Nov 11, 2008
Kind
B2
Abstract

The ability of a polysaccharide to act as an immunostimulant may be assessed by comparing the degree of binding of a detection reagent, which contains a fluorescence-labeled version of the polysaccharide, with the binding of a reference reagent, which contains a fluorescence-labeled version of a different polysaccharide. The ability of a polysaccharide to act as an immunostimulant may also be assessed by comparing the degree of binding of a detection reagent, which contains a fluorescence-labeled version of the polysaccharide, with the binding of a different type of reference reagent, which contains both the same fluorescence-labeled version of the polysaccharide and an unlabelled version of the same polysaccharide.

Claims (22)

1. A method for estimating an immunostimulant activity of a polysaccharide, which comprises:

(i) obtaining a peripheral blood sample which contains peripheral blood mononuclear cells from a mammal;

(ii) contacting a first portion of said blood sample with a detection reagent comprising a fluorescence-labeled immunostimulant polysaccharide, which contains a first polysaccharide moiety, to obtain a first fraction which comprises target peripheral blood mononuclear cells;

(iii) measuring fluorescent intensity of said first fraction to determine the amount (B) of said target peripheral blood mononuclear cells bonded to said fluorescence-labeled immunostimulant polysaccharide;

(iv) contacting a second portion of said blood sample with a reference reagent comprising a fluorescence-labeled polysaccharide, which contains a second polysaccharide moiety which is different from said first polysaccharide moiety, to obtain a second fraction which comprises target peripheral blood mononuclear cells;

(v) measuring fluorescent intensity of said second fraction to determine the amount (A) of said target peripheral blood mononuclear cells bonded to said fluorescence-labeled polysaccharide; and

(vi) correlating the difference (B−A) between the amounts (A) and (B) with the immunostimulant activity of said first polysaccharide moiety for said mammal.

2. The method of claim 1 , wherein said contacting of said first portion of said blood sample with said detection reagent is carried out at a temperature ranging from 0 to 50° C.

3. The method of claim 2 , wherein said immunostimulant polysaccharide is a β-glucan.

4. The method of claim 3 , wherein said immunostimulant polysaccharide is lentinan.

5. A method for estimating an immunostimulant activity of a polysaccharide, which comprises:

(i) obtaining a peripheral blood sample which contains peripheral blood mononuclear cells from a mammal;

(ii) contacting a first portion of said blood sample with a detection reagent comprising a fluorescence-labeled immunostimulant polysaccharide, which contains a first polysaccharide moiety, to obtain a first fraction which comprises target peripheral blood mononuclear cells;

(iii) measuring fluorescent intensity of said first fraction to determine the amount (B) of said target peripheral blood mononuclear cells bonded to said fluorescence-labeled immunostimulant polysaccharide;

(iv) contacting a second portion of said blood sample with a reference reagent which comprises:

(a) an immunostimulant polysaccharide which is not labeled with any fluorescent material and which has a polysaccharide moiety identical to said first polysaccharide moiety; and

(b) said detection reagent, to obtain a second fraction which comprises target peripheral blood mononuclear cells;

v) measuring fluorescent intensity of said second fraction to determine the amount (A) of said target peripheral blood mononuclear cells bonded to said fluorescence-labeled immunostimulant polysaccharide; and

(vi) correlating the difference (B−A) between the amounts (A) and (B) with the immunostimulant activity of said first polysaccharide moiety for said mammal.

6. The method of claim 5 , wherein said contacting of said first portion of said blood sample with said detection reagent is carried out at a temperature ranging from 0 to 50° C.

7. The method of claim 6 , wherein said immunostimulant polysaccharide is a β-glucan.

8. The method of claim 7 , wherein the said immunostimulant polysaccharide is lentinan.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: AJINOMOTO CO., INC.
To: EA PHARMA CO., LTD.
Reel/Frame 039094/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2006
From: SUGA, TETSUYA; SUGA, YASUYO; MURATA, MASAHIRO
To: AJINOMOTO CO., INC.
Reel/Frame 018531/0005 →
Priority Claims (3)
JP 2004-121616 · Apr 16, 2004 · national
JP 2004-233513 · Aug 10, 2004 · national
JP 2005-036312 · Feb 14, 2005 · national
Continuity (2)
Continuation PCTJP200500730600 · Apr 15, 2005
Related Publication 20070031898A1 · Feb 8, 2007